Part, Chapter, Paragraph
1 II, 5. 4. 8| gradient. Proc Natl Acad Sci U S A. 14;104(33):13225-
2 II, 5. 5. 3| sclerosis in Cyprus. J Neurol Sci 103:29-36.~Milanov I, Georgiev
3 II, 5. 5. 3| Croatia and Slovenia. J Neurol Sci 247:169-172.~Piperidou HN,
4 II, 5. 5. 3| critical overview. Can J Neurol Sci 20:17-29.~Sarasoja T, Wikström
5 II, 5. 5. 3| Parkinson's disease. J Neurol Sci. 262:37-44.~Errea JM, Ara
6 II, 5. 5. 3| Parkinson’s disease. J Neurol Sci 217(2):169-174.~Granieri
7 II, 5. 6. 6| Whitehall II Study. Soc Sci Med 40:189-197~Symmons D,
8 II, 9. 4. 7| study, J Gerontol A Biol Sci Med Sci, (12), p.1277-84.~
9 II, 9. 4. 7| Gerontol A Biol Sci Med Sci, (12), p.1277-84.~DECODE
10 II, 9. 5. 6| determinants of health. Soc Sci Med 58(12):2585-2600~ ~De
11 III, 10. 1. 3| and research issues. Med Sci Sports Exerc 31(11) Suppl
12 III, 10. 1. 3| for energy balance. Med Sci Sports Exerc 29(8):1076-
13 III, 10. 1. 3| interactive effects. Med Sci Sports Exerc 26(7):838-843. ~ ~
14 III, 10. 3. 2| palladium and rhodium.~ ~Environ Sci Technol 35:835-839, quoted
15 III, 10. 5. 1| Sweden. In: Ann. N.Y. Acad. Sci. 1023: 308-322 (2004).~Em M (
